Stockscreener 앱 받기
3.62
2.95%
-0.11
시간 외 거래:
3.69
0.07
+1.93%
전일 마감가:
$3.73
열려 있는:
$3.85
하루 거래량:
540.28K
Relative Volume:
1.31
시가총액:
$216.77M
수익:
-
순이익/손실:
$-40.33M
주가수익비율:
-2.0223
EPS:
-1.79
순현금흐름:
$-39.53M
1주 성능:
-2.16%
1개월 성능:
+32.12%
6개월 성능:
-18.28%
1년 성능:
+20.67%
1일 변동 폭
$3.60
$3.85
1주일 범위
$3.60
$3.95
52주 변동 폭
$2.375
$5.54
Eledon Pharmaceuticals Inc Stock (ELDN) Company Profile
명칭
Eledon Pharmaceuticals Inc
전화
949-238-8090
주소
19800 MACARTHUR BLVD., IRVINE
ELDN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELDN
Eledon Pharmaceuticals Inc
|
3.62 | 223.36M | 0 | -40.33M | -39.53M | -1.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Eledon Pharmaceuticals Inc Stock (ELDN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-18 | 재개 | H.C. Wainwright | Buy |
| 2025-01-28 | 개시 | Guggenheim | Buy |
| 2022-05-13 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-03-23 | 개시 | Cantor Fitzgerald | Overweight |
Eledon Pharmaceuticals Inc 주식(ELDN)의 최신 뉴스
What drives Eledon Pharmaceuticals Inc. stock priceHigh-yield investments - PrintWeekIndia
Is Eledon Pharmaceuticals Inc. a good long term investmentConsistently high returns - PrintWeekIndia
Should I buy Eledon Pharmaceuticals Inc. stock before earningsFree Market Volatility Navigation Tips - jammulinksnews.com
Eledon Pharmaceuticals (ELDN) Receives Buy Rating from Craig-Hallum | ELDN Stock News - GuruFocus
What analysts say about Eledon Pharmaceuticals Inc. stockSkyrocketing returns - PrintWeekIndia
Can Eledon Pharmaceuticals Inc. stock recover from recent declineExponential wealth increase - jammulinksnews.com
Eledon Pharmaceuticals Advances Kidney Transplant Study with Tegoprubart - TipRanks
Eledon Pharmaceuticals Inc. Stock Analysis and ForecastBreakout stock performance - jammulinksnews.com
How Eledon Pharmaceuticals Inc. stock performs during market volatilityDefensive Stock Picks with Upside - Newser
Is Eledon Pharmaceuticals Inc. stock a good hedge against inflationFree Access to Community - beatles.ru
Midday Stock Roundup: loanDepot Shoots Up 16% - Orange County Business Journal
Updated Data from Eledon Pharmaceuticals’ Ongoing Phase 1b - GlobeNewswire
Eledon to present updated kidney transplant study data at WTC By Investing.com - Investing.com Nigeria
Eledon to present updated kidney transplant study data at WTC - Investing.com
New Phase 1b Data: Tegoprubart Shows Promise in Preventing Kidney Transplant Rejection30 Patient Update - Stock Titan
Why Eledon Pharmaceuticals Inc. stock attracts strong analyst attentionWeekly Double Return List - Newser
What makes Eledon Pharmaceuticals Inc. stock price move sharplyWealth Accumulation Stock List - Newser
Best Momentum Stocks to Buy for July 14th - TradingView
What is Lifesci Capital’s Estimate for ELDN Q2 Earnings? - Defense World
Eledon Pharmaceuticals Inc (ELDN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.97%
0.22%
자본화:
|
볼륨(24시간):